Matthew Taylor
Stock Analyst at Jefferies
(3.40)
# 992
Out of 5,136 analysts
183
Total ratings
63.06%
Success rate
11.16%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Taylor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GEHC GE HealthCare Technologies | Maintains: Buy | $95 → $105 | $85.30 | +23.09% | 3 | Dec 11, 2025 | |
| PODD Insulet | Maintains: Neutral | $320 → $355 | $282.94 | +25.47% | 16 | Nov 7, 2025 | |
| EW Edwards Lifesciences | Upgrades: Buy | $80 → $98 | $83.10 | +17.93% | 20 | Oct 29, 2025 | |
| SI Shoulder Innovations | Initiates: Buy | $19 | $13.55 | +40.22% | 1 | Aug 25, 2025 | |
| ABT Abbott Laboratories | Upgrades: Buy | $143 → $145 | $125.00 | +16.00% | 17 | Jul 18, 2025 | |
| INMD InMode | Maintains: Hold | $16 → $15 | $14.04 | +6.84% | 7 | Apr 14, 2025 | |
| MDT Medtronic | Maintains: Sell | $75 → $76 | $98.74 | -23.03% | 17 | May 24, 2024 | |
| ALUR Allurion Technologies | Initiates: Buy | $125 | $1.76 | +7,022.51% | 1 | Feb 9, 2024 | |
| MASI Masimo | Downgrades: Hold | $107 → $121 | $138.41 | -12.58% | 9 | Jan 30, 2024 | |
| OBIO Orchestra BioMed Holdings | Initiates: Buy | $14 | $4.46 | +213.90% | 1 | Jan 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $45 | $20.87 | +115.62% | 2 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $10 | $7.16 | +39.66% | 1 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $58 → $53 | $12.53 | +322.98% | 2 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $22 → $24 | $13.68 | +75.44% | 2 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $345 | $359.39 | -4.00% | 14 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | $115 → $130 | $89.24 | +45.67% | 8 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $230 | $313.43 | -26.62% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $17.44 | +14.68% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $85 | $41.58 | +104.43% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $92.46 | -18.88% | 7 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $245 | $259.51 | -5.59% | 7 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $62 | $19.84 | +212.50% | 8 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $210 | $103.05 | +103.78% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $15.95 | -24.76% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $69.70 | +79.34% | 12 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $93.74 | -46.66% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $210 | $546.76 | -61.59% | 12 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $96 | $60.86 | +57.74% | 3 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $7 | $4.95 | +41.41% | 1 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $266 | $207.42 | +28.24% | 4 | May 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $16 | $10.23 | +56.40% | 2 | Jul 19, 2017 |
GE HealthCare Technologies
Dec 11, 2025
Maintains: Buy
Price Target: $95 → $105
Current: $85.30
Upside: +23.09%
Insulet
Nov 7, 2025
Maintains: Neutral
Price Target: $320 → $355
Current: $282.94
Upside: +25.47%
Edwards Lifesciences
Oct 29, 2025
Upgrades: Buy
Price Target: $80 → $98
Current: $83.10
Upside: +17.93%
Shoulder Innovations
Aug 25, 2025
Initiates: Buy
Price Target: $19
Current: $13.55
Upside: +40.22%
Abbott Laboratories
Jul 18, 2025
Upgrades: Buy
Price Target: $143 → $145
Current: $125.00
Upside: +16.00%
InMode
Apr 14, 2025
Maintains: Hold
Price Target: $16 → $15
Current: $14.04
Upside: +6.84%
Medtronic
May 24, 2024
Maintains: Sell
Price Target: $75 → $76
Current: $98.74
Upside: -23.03%
Allurion Technologies
Feb 9, 2024
Initiates: Buy
Price Target: $125
Current: $1.76
Upside: +7,022.51%
Masimo
Jan 30, 2024
Downgrades: Hold
Price Target: $107 → $121
Current: $138.41
Upside: -12.58%
Orchestra BioMed Holdings
Jan 19, 2024
Initiates: Buy
Price Target: $14
Current: $4.46
Upside: +213.90%
Oct 2, 2023
Maintains: Buy
Price Target: $47 → $45
Current: $20.87
Upside: +115.62%
Jul 19, 2023
Initiates: Underperform
Price Target: $10
Current: $7.16
Upside: +39.66%
Jul 12, 2023
Upgrades: Buy
Price Target: $58 → $53
Current: $12.53
Upside: +322.98%
May 24, 2023
Maintains: Hold
Price Target: $22 → $24
Current: $13.68
Upside: +75.44%
May 2, 2023
Maintains: Buy
Price Target: $320 → $345
Current: $359.39
Upside: -4.00%
Mar 31, 2023
Upgrades: Hold
Price Target: $115 → $130
Current: $89.24
Upside: +45.67%
Oct 12, 2022
Initiates: Buy
Price Target: $230
Current: $313.43
Upside: -26.62%
Oct 12, 2022
Initiates: Buy
Price Target: $20
Current: $17.44
Upside: +14.68%
Oct 12, 2022
Initiates: Hold
Price Target: $85
Current: $41.58
Upside: +104.43%
Oct 12, 2022
Initiates: Buy
Price Target: $75
Current: $92.46
Upside: -18.88%
Oct 12, 2022
Initiates: Hold
Price Target: $245
Current: $259.51
Upside: -5.59%
Oct 12, 2022
Initiates: Hold
Price Target: $62
Current: $19.84
Upside: +212.50%
Oct 12, 2022
Initiates: Hold
Price Target: $210
Current: $103.05
Upside: +103.78%
Oct 12, 2022
Initiates: Buy
Price Target: $12
Current: $15.95
Upside: -24.76%
Oct 12, 2022
Initiates: Buy
Price Target: $125
Current: $69.70
Upside: +79.34%
Oct 12, 2022
Initiates: Buy
Price Target: $50
Current: $93.74
Upside: -46.66%
Oct 12, 2022
Initiates: Hold
Price Target: $210
Current: $546.76
Upside: -61.59%
Feb 24, 2022
Upgrades: Buy
Price Target: $96
Current: $60.86
Upside: +57.74%
Dec 17, 2021
Initiates: Neutral
Price Target: $7
Current: $4.95
Upside: +41.41%
May 13, 2019
Upgrades: Overweight
Price Target: $266
Current: $207.42
Upside: +28.24%
Jul 19, 2017
Maintains: Equal-Weight
Price Target: $17 → $16
Current: $10.23
Upside: +56.40%